Results suggest that LL-37 peptide linked to MNPs (MNP@LL-37) have a therapeutic role with a higher rate in treatment and management of cancer compared with treatment using free LL-37 peptide (Niemirowicz et al., 2015). The gene discussed is CAMP; the disease is cancer.